Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03833271Phase 1Completed
Phase 1, open-label trial of 3Fluart in influenza (3 arms), sponsored by University of Pécs. Primary endpoints: Immune function comparison and Rate of seroconversion. Started Oct 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03833271.